The prevalence and burden of arthritis, Rheumatology, vol.41, issue.suppl_1, pp.3-6, 2002. ,
DOI : 10.1093/rheumatology/41.S1.3
Therapeutic targets in osteoarthritis: from today to tomorrow with new imaging technology, Annals of the Rheumatic Diseases, vol.62, issue.90002, pp.79-82, 2003. ,
DOI : 10.1136/ard.62.suppl_2.ii79
Pathobiology of Osteoarthritis: Pathomechanisms and Potential Therapeutic Targets, Current Drug Targets, vol.8, issue.2, pp.271-82, 2007. ,
DOI : 10.2174/138945007779940160
Disposition and metabolism of two acetylcholinesterase reactivators, pyrimidoxime and HI6, in rats submitted to organophosphate poisoning, Xenobiotica, vol.1, issue.7, pp.699-709, 1990. ,
DOI : 10.1016/S0272-0590(81)80057-7
In vitro binding of oxime acetylcholinesterase reactivators to proteoglycans synthesized by cultured chondrocytes and fibroblasts, Biochemical Pharmacology, vol.44, issue.10, pp.1927-1960, 1992. ,
DOI : 10.1016/0006-2952(92)90094-Y
Autoradiographic studies on the distribution of quaternary ammonium compounds. III. Distribution, excretion and metabolism of 14C-labeled pancuronium bromide in rats., CHEMICAL & PHARMACEUTICAL BULLETIN, vol.22, issue.11, pp.2502-2512, 1974. ,
DOI : 10.1248/cpb.22.2502
Synthesis ofN-quaternary ammonium [3H] and [99mTc]polyazamacrocycles, potential radiotracers for cartilage imaging, Journal of Labelled Compounds and Radiopharmaceuticals, vol.43, issue.6, pp.585-94, 2000. ,
DOI : 10.1002/(SICI)1099-1344(200005)43:6<585::AID-JLCR343>3.0.CO;2-H
Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use for treatment or diagnosis of pathologies affecting cartilage, 2001. ,
Disposition in rats of N-pyridinium-propyl-cyclam, N-triethylammoniumpropyl-cyclam , and N-[Triethylammonium]-3-propyl-[15]ane-N5, potential cartilage imaging agents, Drug Metab Dispos, vol.28, pp.418-440, 2000. ,
New Quaternary Ammonium Oxicam Derivatives Targeted toward Cartilage:?? Synthesis, Pharmacokinetic Studies, and Antiinflammatory Potency, Journal of Medicinal Chemistry, vol.42, issue.25, pp.5235-5275, 1999. ,
DOI : 10.1021/jm991120o
Joint scintigraphy in rabbits with 99mtc-N-[3-(triethylammonio)propyl]- 15ane-N5, a new radiodiagnostic agent for articular cartilage imaging, J Nucl Med, vol.42, pp.141-146, 2001. ,
First In Vivo SPECT imaging of Mouse Femorotibial Cartilage using 99mTc-NTP 15-5, Mol Imaging, vol.7, pp.263-71, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-01505259
Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy, European Journal of Nuclear Medicine and Molecular Imaging, vol.42, issue.Suppl A, pp.1280-90, 2007. ,
DOI : 10.1007/s00259-006-0320-2
Quantitative assessment of articular cartilage and subchondral bone histology in the meniscectomized guinea pig model of osteoarthritis, Osteoarthritis and Cartilage, vol.11, issue.6, pp.412-435, 2003. ,
DOI : 10.1016/S1063-4584(03)00050-5
Expression of proteoglycans and collagen in the hypertrophic phase of experimental osteoarthritis, J Rheumatol, vol.43, pp.94-101, 1995. ,
Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis, Arthritis Research, vol.3, issue.2, pp.107-120, 2001. ,
DOI : 10.1186/ar148
Cartilage Tumors: Evaluation and Treatment, Journal of the American Academy of Orthopaedic Surgeons, vol.8, issue.5, pp.292-304, 2000. ,
DOI : 10.5435/00124635-200009000-00003
First Preclinical Imaging of Primary Cartilage Neoplasm and Its Local Recurrence Using 99mTc-NTP 15-5 Radiotracer, Journal of Nuclear Medicine, vol.50, issue.9, 2009. ,
DOI : 10.2967/jnumed.108.056721
PET Scanning with 18F 2-Fluoro-2-Deoxy-?-Glucose (FDG) in Patients with Melanoma Benefits and Limitations, Clinical Positron Imaging, vol.2, issue.2, pp.93-101, 1999. ,
DOI : 10.1016/S1095-0397(99)00006-0
Tumor immunoscintigraphy by means of radiolabeled monoclonal antibodies: multicenter studies of the Italian National Research Council Special Project ''Biomedical Engineering, Cancer Res, vol.1, pp.899-903, 1990. ,
Early detection of melanoma metastases with radioiodinated methylene blue ,
Radioiodinated N-[3-(4-morpholino)propyl]-N-methyl-2-hydroxy-5-iodo-3-methylbenzylamine (ERC9): a new potential melanoma imaging agent, European Journal of Nuclear Medicine, vol.28, issue.4, pp.408-425, 2001. ,
DOI : 10.1007/s002590000455
Synthèse, étude chez le rat, de composés radioiodés utilisables pour l'exploration du système nerveux central, Eur J Med Chem, vol.21, pp.423-454, 1986. ,
Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma, J Nucl Med, vol.32, pp.1573-80, 1991. ,
Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-Diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents, Nuclear Medicine and Biology, vol.22, issue.6, pp.737-784, 1995. ,
DOI : 10.1016/0969-8051(95)00020-X
Agents pour le diagnostic et le traitement des mélanomes, dérivés halogénés utilisables comme de tels agents et leur préparation, 1990. ,
Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation, 1990. ,
Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma, J Nucl Med, vol.37, pp.1865-71, 1996. ,
Pharmacokinetics of iodine-123-IMBA for melanoma imaging, J Nucl Med, vol.38, pp.127-160, 1997. ,
Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo, J Nucl Med, vol.39, pp.996-1001, 1998. ,
Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy- N -[(1-ethyl-2-pyrrolidinyl)methyl]benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.12, pp.1567-71, 1999. ,
DOI : 10.1007/s002590050496
Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent, Melanoma Research, vol.12, issue.2, pp.115-136, 2002. ,
DOI : 10.1097/00008390-200204000-00003
A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)-4- iodobenzamide, J Nucl Med, vol.34, pp.2169-75, 1993. ,
Synthesis and Evaluation of Novel Radioiodinated Benzamides for Malignant Melanoma, Journal of Medicinal Chemistry, vol.50, issue.15, pp.3561-72, 2007. ,
DOI : 10.1021/jm0701627
Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation, Nuclear Medicine and Biology, vol.32, issue.5, pp.451-459, 2005. ,
DOI : 10.1016/j.nucmedbio.2005.04.006
Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I- BZA and (14)C-I-BZA, J Nucl Med, vol.46, pp.1701-1707, 2005. ,
Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences, Biomed Eng online, vol.6, p.10, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-00112916
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide), J Nucl Med, vol.34, pp.1260-1266, 1993. ,
123 I- N -(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging, European Journal of Nuclear Medicine and Molecular Imaging, vol.29, issue.11, pp.1478-84, 2002. ,
DOI : 10.1007/s00259-002-0971-6
Synthesis, characterization and comparative biodistribution study of a new series of p -Iodine-125 benzamides as potential melanoma imaging agents, Nuclear Medicine and Biology, vol.28, issue.7, pp.799-808, 2001. ,
DOI : 10.1016/S0969-8051(01)00242-6
Labelled analogues of halobenzamides as radiophamraceuticals, 2008. ,
-(2-diethylaminoethyl)-4-iodobenzamide for Imaging and Targeted Radionuclide Therapy of Melanoma, Journal of Medicinal Chemistry, vol.51, issue.11, pp.3133-3177, 2008. ,
DOI : 10.1021/jm701424g
Chezal Jm, Moins N. [131I]ICF01012, a potential agent for targeted radionuclide therapy of melanoma, Abstracts World Molecular Imaging Congress, pp.8-810, 2008. ,
Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent, Nucl Med Biol, vol.99, pp.783-91, 2008. ,